1/14
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
Describe the different types of bleeding patients may present with and correlate this to the hemostatic mechanism most likely dysfunctioning
Primary
Skin and mucous membranes
Purpura
Petechiae
Ecchymoses
Epistaxis
Menorrhagia
Secondary
Deeper tissues
Hemartjrosis
Hematuria
Define and Differentiate petechiae, ecchymosis, and hematoma
Petechaie
Similar to a rash
Ecchymosis
A bruise
Hematoma
Fluid acclimation
Correlate clinical findings and screening tests results to the most likely source of primary hemostatic dysfunction
-
Outline the diagnostic work-up required for a patient presenting with bleeding
Background information
Lab test
CBC
PT
aPTT
List the two major problems that occur to the vasculature when a hereditary defect is present in a patient
weakened vessel walls and abnormal vessel development
Associate the hereditary defect of the vasculature with its impact on normal blood vessel integrity
List the four etiologies of acquired disorders of vascular function
Define thrombocytopenia and thrombocytosis
List the three major etiological groups of thrombocytopenia
Impaired production
Increased destruction
Distribution abnormality
Describe the etiology, pathophysiology, clinical features, and laboratory findings of the following quantitative defects of platelets:
Idiopathic thrombocytopenic purpura
thrombotic thrombocytopenic purpura
Post-transfusion purpura
Disseminated intravascular coagulation
Hemolytic uremic syndrome
Neonatal alloimmune thrombocytopenia
Heparin-induced thrombocytopenia
Drug-induced immune thrombocytopenia
Describe the etiology, pathophysiology, clinical features, and laboratory findings of the following quantitative defects of platelets:
von Willebrand’s disease
Bernard-Soulier syndrome
Large Platelet disease
Mutation in gene that codes for GPIb, Chromosome 17 and 22, GP IX, Chromosome 3
inappropriate adhesion to collagen
Manifested in infancy or childhoos
severe bleeding (seldom)
Brusing
epitaxis
gingivial bleeding
Lab Values
prolong bleeding time (20 minutes)
platelet count decreased (50,000 - 80,000)
giant platlets
platlet aggregation
Absent with thrombonin
absent with bovine vWF or ristocetin
normal ADP, collagen and epinephrine
Glanzmann’s thrombasthenia
Autosomal recessive inheritance pattern
Mutation in GPIIb, chromosome 17, GP IIIa, chromosome 17
platlet aggregation can not occur
appear in infancy or childhood
severe and debilitating bleeding episodes
Lab values
Normal platelet count
prolong bleeding time
platelet aggregation
no complete response to agonist
Storage pool deficiencies
Dense granule def.
Alpha granule def
Other
Describe and differentiate the different subtypes of vWF
Describe the different laboratory tests used to examine vWF activity
Correlate platelet aggregation results to Bernard-Soulier Syndrome, vonWillebrand Disease, Glanzmann Thrombasthenia, and storage pool disorders
Determine the most likely defect of primary hemostasis when provided a case study